Discretionary/ Grant (2024)
Notice of Intent to Publish a Funding Opportunity Announcement for Intellectual and Developmental Disabilities Research Centers 2025 (P50 Clinical Trial Optional)
Grant (2024):Heads Up! Funding Opportunity Coming Soon: Intellectual and Developmental Disabilities Research Centers
The National Institutes of Health (NIH) is planning to release a grant opportunity for Intellectual and Developmental Disabilities Research Centers (IDDRCs). This is a heads-up to allow researchers time to prepare.
Here’s what we know so far:
- Grant Program: Intellectual and Developmental Disabilities Research Centers (P50 Clinical Trial Optional)
- Funding Agency: National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Estimated Posting Date: July 26, 2024
- Estimated Application Due Date: November 26, 2024
- Expected Award Ceiling: $1,000,000
Who can Apply?
- A variety of organizations are eligible, including non-profits, universities, government agencies, and even small businesses. See the full announcement for details.
What will IDDRCs do?
- Support research on diagnosing, preventing, treating, and improving the lives of people with intellectual and developmental disabilities (IDD).
- Encourage collaboration between researchers in different fields.
Stay Tuned!
The official announcement with full details is expected in July 2024. Keep an eye out for the Notice of Funding Opportunity (NOFO) titled “Notice of Intent to Publish a Funding Opportunity Announcement for Intellectual and Developmental Disabilities Research Centers 2025 (P50 Clinical Trial Optional)”.
What are IDDRCs?
- IDDRCs are specialized research centers funded by the NIH to focus on intellectual and developmental disabilities (IDD).
- Each center is expected to conduct a variety of research activities, including:
- Basic research: Gaining fundamental knowledge about IDD.
- Translational research: Applying basic research findings to develop new therapies or interventions.
- Clinical research: Testing new therapies or interventions in people with IDD.
What is the goal of the funding?
The goal is to support research that will ultimately improve the lives of people with IDD by:
- Developing better methods for diagnosing IDD.
- Creating new strategies to prevent IDD.
- Finding more effective treatments for IDD.
- Improving supports and services for people with IDD and their families.
Key Details
- Grant Program: Intellectual and Developmental Disabilities Research Centers (P50 Clinical Trial Optional) – The “P50” designation indicates a multi-project grant that supports a center with various research activities. The “Clinical Trial Optional” part means the center may or may not include clinical trials as part of its research.
- Funding Agency: National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Estimated Posting Date: July 26, 2024
- Estimated Application Due Date: November 26, 2024
- Expected Award Ceiling: $1,000,000 (This is the maximum amount a single award can be. The total program funding may be higher depending on the number of awards given.)
Who can Apply?
A wide range of organizations are eligible to apply, including:
- Non-profit organizations with 501(c)(3) status (excluding universities)
- Tribal governments (federally recognized)
- State and local governments
- Public and private institutions of higher education
- Small businesses
- For-profit organizations (excluding small businesses)
- Tribal organizations (other than federally recognized)
What the Announcement Will Likely Include
The official announcement (expected in July 2024) will provide full details about the program, including:
- Specific research priorities for the IDDRCs
- Required components of an IDDRC
- Evaluation criteria for applications
- Instructions for submitting an application
Stay Tuned!
Keep an eye out for the official announcement titled “Notice of Funding Opportunity (NOFO) for Intellectual and Developmental Disabilities Research Centers 2025 (P50 Clinical Trial Optional)”. This will provide all the information you need to apply.
